CDC / RDC · All levels

CDC Review Gate: Design Space

Design Space for CDC Review Gate.

Design space exploration

For CDC Review Gate, signoff options trade reliability, latency, and schedule.

Option A — conservative

  • Conservative synchronization: helps robustness

  • Risk: latency increase

  • Validate with: stress regressions

Option B — balanced

  • Balanced protocol design: helps throughput + safety

  • Risk: higher design effort

  • Validate with: formal + simulation

Option C — aggressive

  • Aggressive waiver posture: helps schedule relief

  • Risk: escape risk

  • Validate with: periodic waiver audit

Option D — refactor

  • Architectural refactor: helps long-term safety

  • Risk: schedule hit

  • Validate with: system bring-up

diagram
DESIGN SPACE — CDC Review Gate
robustness <-> latency <-> complexity <-> schedule

Design pitfalls

  • Waive-first behavior

  • No owner for residual risk

Tradeoff curve

diagram
BEFORE / AFTER — CDC Review Gate

open critical issues
  ^
  |  o baseline
  |     o after fix batch
  |         o after protocol proof
  |             o signoff-ready
  +---------------------------------> closure iteration

Track issue burn-down with evidence quality, not only count.

CDC/RDC deep dive

Signoff is an evidence governance problem across teams.

Concept diagram

diagram
CDC SIGNOFF LOOP

analysis -> triage -> fix/waive -> review gate -> dashboard

Metric graph

diagram
CRITICAL OPEN COUNT

week1 34
week2 22
week3 10
week4 0

Reports and artifacts

  • critical by owner

  • waiver quality

  • review gate status

  • closure trend

Mini case study

Pass rates improved while critical waivers aged out of policy; dashboard exposed hidden risk.

Debug branches

  • Separate quality from quantity metrics

  • enforce waiver expiry

  • run gate checklists consistently

Senior review question

Ask: what evidence proves this risk is closed for silicon, not just tool-clean?

Key takeaways

  • State crossing class, assumptions, and owner with every issue.

  • Run structural and dynamic regressions after each fix.

Common pitfalls

  • Treating all warnings as equivalent risk.

  • Waiving issues without containment evidence.

  • Skipping reset and reconvergence stress after CDC fixes.

Principal CDC/RDC review addendum

Gate reviews align RTL, verification, and signoff evidence before integration milestones to avoid endgame metastability surprises.

Metric: gate pass rate, late-stage CDC churn, review defect leakage